ReviewOncoTargets and therapy2023

Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights.

Annesha Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.